Company profile & Management

Sensible Medical Innovations is the market leader in medical radar (ReDS™) monitoring and imaging technology. ReDS™ was adapted for medical use from military ‘see-through-wall’ technology. The technology is well-positioned to be a game changer in a wide range of applications and to become the next-generation lung fluid monitoring modality.

Vision – Striving to lead a new
Standard of Care in Heart Failure

ReDS™ enables the noninvasive monitoring and management of patients with fluid management problems. Lung fluid levels matter in the treatment of Heart Failure patients, and ReDS™ is designed with the needs of these patients in mind.

Sensible Medical is striving to lead the way toward a new standard of care for Heart Failure (HF), by giving healthcare professionals and patients a credible tool in the measurement of lung fluid, inside and outside the clinic setting.

Mission – To Empower Heart Failure
Professionals and Patients

Through ReDS™, Sensible Medical empowers Heart Failure professionals and patients by providing accurate, actionable, and absolute lung fluid measurements across the continuum of care. Our groundbreaking ReDS™ technology monitors the patient’s lung fluid status and serves as a decision support tool for physicians, providing them with valuable information in determining the right course of treatment. ReDS™ opens the possibility for physicians to deliver adequate treatment while their patients are still in an asymptomatic stage of fluid accumulation, which, when combined with other treatments, may help prevent symptoms that could lead to harmful Heart Failure deterioration in the future.

Management team

Amir Ronen,

CEO

 

Tzvia Broida,

CFO

 

Eran Kurman,

VP Sales and Marketing

 

Amir Ronen, CEO

Amir Ronen co-founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care.
Prior to founding Sensible Medical, he served as the vice president in two NASDAQ traded companies (NSDQ: FLSH, SFUN) and played a leading role in the strategy planning at Intel Corporation (NSDQ: INTC). Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Tzvia Broida, CFO

Tzvia Broida joined Sensible Medical in 2011 as Chief Financial Officer. Prior to joining Sensible Medical, Tzvia Broida served as a member of the executive team of Jacada, (NASDAQ: JCDA). From 1995 to 2009, Ms. Broida worked at Jacada in executive finance roles of increasing responsibility. Most recently, Ms. Broida served as the CFO for Jacada. In her role as CFO, Ms. Broida took an active role in the company’s strategic processes, managed and participated in numerous M&A and Due Diligence processes, and led the organization’s Corporate Accounting, Finance, and Investor Relations functions.
Prior to Jacada, Ms. Broida worked as an accountant at the accounting firm of Yehuda Ehrlich & Partners and at the accounting firm of Vexler, Kodenzick & Partners. Ms. Broida holds a B.A. in Accounting and Economics, from the Hebrew University of Jerusalem and is a CPA and member of the Israeli Society of Certified Public Accountants.

Eran Kurman, VP Sales & Marketing

Eran Kurman joined Sensible Medical in October 2015 as VP of Sales and Marketing. Prior to joining Sensible Medical, Mr. Kurman was VP of Global Commercial Strategy at Labstyle Innovations.
From 2001 to 2015, Mr. Kurman held marketing positions of increasing responsibility with companies such as Ethicon Inc., a Johnson and Johnson company, and Lumenis Ltd. In his most recent role as VP Global Commercialization Strategy, Mr. Kurman built and led the strategic commercial planning and execution of an innovative diabetes monitoring product for LabStyle Innovations. Mr. Kurman began his career with QuintilesIMS as a CRA.
Mr. Kurman holds a B.Med.Sc from the Ben-Gurion University and an M.A. in Business Administration from the University of Haifa.

Nahum Hai,

COO

 

Amir Saroka,

CTO

 

Shlomi Bergida,

VP Product Management

 

Nahum Hai, COO

Nahum Hai joined Sensible Medical in 2010 as Chief Operating Officer. Prior to joining Sensible Medical, Mr. Hai led the departments of VAS Engineering, Service Development, and 3G Engineering at Cellcom, (NYSE:CEL), Israel’s largest cellular operator.
From 2001 to 2010, Mr. Hai worked at Cellcom in roles of increasing responsibility. Most recently, Mr. Hai served as the Department Manager of Advanced Services. At Cellcom, Mr. Hai led project/product management, system integrations, and development, and managed the delivery of cross-organizational, complex customer projects that served over 1M active users and generated tens of millions of dollars in revenues. Mr. Hai managed SW development of content delivery platforms and internet applications and was responsible for introducing new products from concept to support. He began his career in the Israel Defense Forces in 1995.
Mr. Hai holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, an M.A. in Business Administration from the Technion – Israel Institute of Technology, and an M.A. in Law with a specialization in Patent Law from Haifa University.

Amir Saroka, CTO

Amir Saroka co-founded Sensible Medical Innovations in 2007, and now serves as Chief Technology Officer. Prior to founding Sensible Medical, Mr. Saroka was the department manager of an elite R&D unit in the Israel Defense Forces.
From 1997 to 2005, Mr. Saroka headed projects for the Israeli Ministry of Defense in the areas of wireless and wired communication, software engineering, embedded software, signal processing, digital circuit design and more.
Mr. Saroka holds an M.Sc. in Electrical Engineering from Tel-Aviv University, and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Shlomi Bergida, VP Product Management

Shlomi Bergida co-founded Sensible Medical in 2007, and now serves as VP of Product Management. Prior to founding Sensible Medical, Mr. Bergida held positions of increasing responsibility with an elite electronics R&D unit in the Israeli Ministry of Defense.
From 1998 to 2006, Mr. Bergida headed various large-scale projects of R&D activities for the Israeli Defense Forces, where he developed his areas of expertise in multidisciplinary system definition, design, and implementation.
Mr. Bergida holds an M.Sc. in Electrical Engineering from Tel-Aviv University in Israel and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Nadav Mizrahi,

VP R&D

 

Guy Frak,

VP Sales International

Nadav Mizrahi, VP R&D

Nadav Mizrahi joined Sensible Medical in 2007 and now serves as VP of R&D. Prior to joining Sensible Medical, Mr. Mizrahi served at an elite electronics R&D unit in the Israeli Ministry of Defense.
From 1998 to 2006, Mr. Mizrahi led the research and development of various digital and analogue platforms designed to fit within high performance and reliable communication systems. During his time with the Israeli Defense Forces, Mr. Mizrahi developed deep expertise in system design, high-performance digital hardware, microwave systems, ASIC and board level design, as well as R&D and QA team management.
Mr. Mizrahi holds an M.Sc. in Bio-Medical Engineering and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Guy Frak, VP Sales International

Mr. Frak has over 20 years of experience in management and Sales positions in international medical devices and biotech companies. In his last position, he served as Managing Director of Biometrix Medical, a medical devices company active in the cardiology and surgical fields, in which he was responsible for the company’s operations, sales and marketing, business development, and others. Prior to that, Mr. Frak served as the President of Mennen Medical, EVP at Wisesec, and at other medical companies as a top executive. Mr. Frak has extensive experience in the global medical devices’ market, and he managed and established distributors worldwide. Mr. Frak holds a BHS & Business degree from Florida Atlantic University.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top-notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor. Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Tzvia Broida, CFO

Tzvia Broida joined Sensible Medical in 2011 as Chief Financial Officer. Prior to joining Sensible Medical, Tzvia Broida served as a member of the executive team of Jacada, (NASDAQ: JCDA). From 1995 to 2009, Ms. Broida worked at Jacada in executive finance roles of increasing responsibility.  Most recently, Ms. Broida served as the CFO for Jacada.  In her role as CFO, Ms. Broida took an active role in the company’s strategic processes, managed and participated in numerous M&A and Due Diligence processes, and led the organization’s Corporate Accounting, Finance, and Investor Relations functions. Prior to Jacada, Ms. Broida worked as an accountant at the accounting firm of Yehuda Ehrlich & Partners and at the accounting firm of Vexler, Kodenzick & Partners. Ms. Broida holds a B.A. in Accounting and Economics, from the Hebrew University of Jerusalem and is a CPA and member of the Israeli Society of Certified Public Accountants.

Eran Kurman, VP Sales & Marketing

Eran Kurman joined Sensible Medical in October 2015 as VP of Sales and Marketing.  Prior to joining Sensible Medical, Mr. Kurman was VP of Global Commercial Strategy at Labstyle Innovations. From 2001 to 2015, Mr. Kurman held marketing positions of increasing responsibility with companies such as Ethicon Inc., a Johnson and Johnson company, and Lumenis Ltd. In his most recent role as VP Global Commercialization Strategy, Mr. Kurman built and led the strategic commercial planning and execution of an innovative diabetes monitoring product for LabStyle Innovations. Mr. Kurman began his career with QuintilesIMS as a CRA. Mr. Kurman holds a B.Med.Sc from the Ben-Gurion University and a M.A. in Business Administration from the University of Haifa.

Nahum Hai, COO

Nahum Hai joined Sensible Medical in 2010 as Chief Operating Officer.  Prior to joining Sensible Medical, Mr. Hai led the departments of VAS Engineering, Service Development, and 3G Engineering at Cellcom, (NYSE:CEL), Israel’s largest cellular operator. From 2001 to 2010, Mr. Hai worked at Cellcom in roles of increasing responsibility. Most recently, Mr. Hai served as the Department Manager of Advanced Services. At Cellcom, Mr. Hai led project/product management, system integrations and development, and managed the delivery of cross-organizational, complex customer projects that served over 1M active users and generated tens of millions of dollars in revenues. Mr. Hai managed SW development of content delivery platforms and internet applications, and was responsible for introducing new products from concept to support. He began his career in the Israel Defense Forces in 1995. Mr. Hai holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, an M.A. in Business Administration from the Technion – Israel Institute of Technology, and an M.A. in Law with a specialization in Patent Law from Haifa University.

Amir Saroka, CTO

Amir Saroka co-founded Sensible Medical Innovations in 2007, and now serves as Chief Technology Officer. Prior to founding Sensible Medical, Mr. Saroka was the department manager of an elite R&D unit in the Israel Defense Forces. From 1997 to 2005, Mr. Saroka headed projects for the Israeli Ministry of Defense in the areas of wireless and wired communication, software engineering, embedded software, signal processing, digital circuit design and more. Mr. Saroka holds an M.Sc. in Electrical Engineering from Tel-Aviv University, and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Shlomi Bergida, VP Product Management

Shlomi Bergida co-founded Sensible Medical in 2007, and now serves as VP of Product Management. Prior to founding Sensible Medical, Mr. Bergida held positions of increasing responsibility with an elite electronics R&D unit in the Israeli Ministry of Defense. From 1998 to 2006, Mr. Bergida headed various large-scale projects of R&D activities for the Israeli Defense Forces, where he developed his areas of expertise in multidisciplinary system definition, design, and implementation. Mr. Bergida holds an M.Sc. in Electrical Engineering from Tel-Aviv University in Israel and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Nadav Mizrahi, VP R&D

Nadav Mizrahi joined Sensible Medical in 2007, and now serves as VP of R&D. Prior to joining Sensible Medical, Mr. Mizrahi served at an elite electronics R&D unit in the Israeli Ministry of Defense. From 1998 to 2006, Mr. Mizrahi led the research and development of various digital and analogue platforms designed to fit within high performance and reliable communication systems. During his time with the Israeli Defense Forces, Mr. Mizrahi developed deep expertise in system design, high performance digital hardware, micro-wave systems, ASIC and board level design, as well as R&D and QA team management. Mr. Mizrahi holds a M.Sc. in Bio-Medical Engineering and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.  

Guy Frak, VP Sales International

Mr. Frak has over 20 years of experience in management and Sales positions in international medical devices and biotech companies. In his last position, he served as Managing Director of Biometrix Medical, a medical devices company active in the cardiology and surgical fields, in which he was responsible for the company’s operations, sales and marketing, business development, and others. Prior to that, Mr. Frak served as the President of Mennen Medical, EVP at Wisesec, and at other medical companies as a top executive. Mr. Frak has extensive experience in the global medical devices’ market, and he managed and established distributors worldwide. Mr. Frak holds a BHS & Business degree from Florida Atlantic University.